Drug Information Association Logo

Conference on Pharmacovigilance & Drug Safety - A New Era

Mar 21 2014 9:00AM - Mar 22 2014 6:00PM | Sci-Tech Centre 7, Prabhatnagar Jogeshwari (W) Mumbai 400102 MH India

« Back to Listing

Featured Topics 

  • Safety management of medical devices
  • Medical information and safety integration
  • Cosmetic vigilance
  • PV harmonization in Asia
  • Cardiac, hepatic and renal safety issues
  • Drug and vaccine safety in public health
  • Tête–à–tête with EU QPPVs
  • Potential career opportunities in PV
  • Challenges in PV outsourcing

Who Should Attend 

Professionals involved in:

  • Pharmacovigilance
  • Clinical Research
  • Risk management
  • Compliance
  • Medical Information
  • Regulatory Affairs
  • Academia
  • Pharmacology

Learning Objectives 

At the conclusion of this conference, participants will be able to:

  • Explain key aspects of current global safety reporting requirements for prescription and over-the-counter drugs
  • Discuss new pragmatic approaches to pharmacovigilance as proposed by the CIOMS working group
  • Describe the regulatory agency clinical safety and pharmacovigilance inspection program in the US, Europe, and Japan
  • Identify best practices for quality assurance in post marketing pharmacovigilance and clinical safety

Hotel & Travel 

VENUE DETAILS
Scitech Center | Mumbai India
7, Prabhat Nagar, Jogeshwari West, Mumbai
*Land Mark: Next To Unichem Limited

CONTACT
Kanchan Patel, Senior Manager, Operations
Kanchan.Patel@diaindia.org
cell: + 91 98.2062.1844

Contact Information 

Manoj Trivedi, Senior Manager Marketing and Program Development, DIA India
Mobile phone: +91-98-1977-7493
Phone: +91-22-6765-3226
Email: Manoj.Trivedi@diaindia.org

Featured Speaker 

Previous Next

Program Committee 

Previous Next

Agenda  

Day 1 Friday, Mar 21, 2014

  • 9:30AM - 10:15AM

    Keynote Address

    Speaker(s):

    • Future Pharmacovigilance
      Ganesh Parkar
      Cluster Head of Pharma and Manufacturing
      Tata Consultancy Services, India
  • 10:45AM - 2:25PM

    Session 1: PV in Public Health

    Speaker(s):

    • Active Surveillance in PV
      Andy Stergachis
      Professor, Epidemiology & Global Health
      University of Washington, United States
    • Compensation in Clinical Trials
      Y K Gupta
      Professor and Head, Department of Pharmacology
      All India Institute of Medical Sciences (AIIMS), India
    • AEFI Surveillance Program in India
      Jyoti Joshi Jain
      Senior Advisor- Immunization safety surveillance
      Public Health Foundation of India, India
    • Capacity Building in Pharmacovigilance
      Sudhakar Bangera
      COO/ Program Director
      Clinical Development Services Agency, India
  • 3:00PM - 5:30PM

    Session 2: PV in EU

    Speaker(s):

    • QPPV’s Challenges in PV Outsourced Activities
      Ute Hoeffner
      EU-QPPV
      Novartis Consumer Health GmbH, Germany
    • Pharmacovigilance System Master File: An Overview - Changes and Challenges
      Seema Jaitly
      Managing director
      Essjay Solutions Ltd, United Kingdom
    • “Tete-a-tete” with QPPVs and “Open Q&A Session” for Delegates
      Ute Hoeffner
      EU-QPPV
      Novartis Consumer Health GmbH, Germany
    • “Tete-a-tete” with QPPVs and “Open Q&A Session” for Delegates
      Seema Jaitly
      Managing director
      Essjay Solutions Ltd, United Kingdom

Day 2 Saturday, Mar 22, 2014

  • 9:15AM - 9:45AM

    Keynote Address

    Speaker(s):

    • C L Balaji
      Managing Director
      Accenture Services Pvt. Ltd., India
  • 10:00AM - 1:00PM

    Session 3: PV Asia

    Speaker(s):

    • Towards PV Harmonization in Asia
      Stewart Geary
      Senior Vice President, Chief Medical Officer
      Eisai Co., Ltd., Japan
    • C L Balaji
      Managing Director
      Accenture Services Pvt. Ltd., India
    • Panel Discussion: The Big Five of PV - Global Outsourcing in PV to India Career Opportunities and Talent Acquisition Future Prospects—Crystal Gazing
      Aparna Patkar
      Lead PV Offerings
      Tata Consultancy Services, India
    • Rajesh Kuppuswamy
      Senior Director
      Cognizant, India
    • Panel Discussion: The Big Five of PV - Global Outsourcing in PV to India Career Opportunities and Talent Acquisition Future Prospects—Crystal Gazing
      Dinesh Kasthuril
      Director Safety and Risk Management
      Sciformix, India
    • Panel Discussion: The Big Five of PV - Global Outsourcing in PV to India Career Opportunities and Talent Acquisition Future Prospects—Crystal Gazing
      Vineet Kacker
      Managing Director
      APCER Pharma, United Kingdom
  • 2:00PM - 5:30PM

    Session 4: An Insight into Cardiovascular, Hepatic and Renal Safety Issues During Drug Risk Benefit Management

    Speaker(s):

    • An insight into Cardiovascular, Hepatic and Renal Safety Issues During Risk Benefit Management
      Vishwas Sovani
      Revogenex, Inc., India
    • An insight into Cardiovascular, Hepatic and Renal Safety Issues During Risk Benefit Management
      Milind Sardesai
      Project Lead & Domain Consultant – Life Sciences
      Tata Consultancy Services, India
    • An insight into Cardiovascular, Hepatic and Renal Safety Issues During Risk Benefit Management
      Mangesh Kulkarni, DrMed
      Group Head, Drug Safety & Epidemiology
      Novartis Healthcare, India
    • Introduction to Medical Information and its Integration with Drug Safety
      Aaron Cockell, MBA
      Medical Information Regional Director, EMEA
      Pfizer Ltd, United Kingdom
    • IT Solutions for Efficient Medical Information Management
      Subbaraju Sagi
      CEO
      TechSol, United States
    • Cosmetic Vigilance
      Mandar A. Kelkar
      Domain Lead, Safety Surveillance and Risk Management
      Tata Consultancy Services, India
    • Management of PV Challenges through Company Acquisitions and Mergers
      Manoj Swaminathan
      Global Safety Lead
      Sun Pharmaceuticals , India

Exhibits  

The Conference on Pharmacovigilance and Drug Safety - A New Era offers interested companies the opportunity to exhibit with a tabletop display.

Tabletop Fee: INR 75,000

Each tabletop includes:

  • One (1) exhibit personnel registration
  • One (1) table
  • One (1) chair

Any staff required above those allotted per tabletop must register as a full attendee incurring full registration fees. Additional expenses associated with the exhibit, including special booths, drayage, lights, phone, carpeting, electrical connections, etc., will be the responsibility of the exhibitor.

Useful Links:

  • Aris Global Software Pvt. Ltd.
  • TechSol Corporation

Registration Fees 

Member

Charitable Nonprofit/Academia Member
Rs3000.00
Member Government
Rs3000.00
Member Standard
Rs6000.00

Non-Member

Charitable Nonprofit/Academia Nonmember
Rs4000.00
NonMember Government
Rs4000.00
NonMember Standard
Rs7000.00
Group Discounts

Register 10 from your company and receive the 11th FREE! Contact our group discount representative for details or call +91.98.2058.7798


A limited number of student registrations are available.
A student is an undergraduate/graduate who can document enrollment in a Signature accredited, degree granting, academic program. Please send completed registration form, copy of student identification, and payment.

CANCELLATION POLICY: On or before MARCH 11, 2014

Cancellations must be in writing and received by March 11, 2014. Registrants who do not cancel in writing by that date and do not attend the event will be responsible for the full registration fee paid. Registrants are responsible for cancelling their own hotel and airline reservations.

DIA reserves the right to alter the venue, if necessary. If an event is cancelled, DIA is not responsible for any airfare, hotel or other costs incurred by registrants.

Upon cancellation, the administrative fee that will be withheld is 75% of the registration fee.

All refunds will be issued in the currency of original payment

 

Register Online
« Back to Listing Back To Top